Omnicare's acquisition of NCS Healthcare
FDA Grants Tovorafenib Approval to Treat Relapsed or Refractory Pediatric Low-Grade Glioma
The approval for tovorafenib (Ojemda) was based on data from the phase 2 FIREFLY-1 trial, in which the therapy demonstrated an overall repose rate of 67%.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Roundup: Biosimilars, Boxed Warning Added for CAR T-Cell Therapies
Check out important updates from the FDA for the week of April 15.
Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval
This approval is the second biosimilar approval for manufacturer Alvotech.
FDA Accepts GSK's BLA for 5-in-1 Meningococcal Vaccine
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
Rx Roundup: Quiz of the Week — April 12, 2024
Test your pharmacy news knowledge with our weekly quiz.
